Pemetrexed potentiates γδ T cell-based immunotherapy in NSCLC through ATM-STING-NF-κB-mediated induction of NKG2D ligands.

Saved in:
Bibliographic Details
Title: Pemetrexed potentiates γδ T cell-based immunotherapy in NSCLC through ATM-STING-NF-κB-mediated induction of NKG2D ligands.
Authors: Hung MY; Department of Medical Research, Advanced Therapeutic & Pharmaceutical Center, China Medical University Hospital, Taichung, Taiwan; Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan., Lin H; Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan; Master in Senior Health and Exercise Science, Tunghai University, Taichung, Taiwan., Li YH; Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan., Cho DY; Department of Medical Research, Advanced Therapeutic & Pharmaceutical Center, China Medical University Hospital, Taichung, Taiwan; Drug Development Center, China Medical University, Taichung, Taiwan; Department of Neurosurgery, Neuropsychiatric Center, China Medical University Hospital, Taichung, Taiwan; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan., Chiu SC; Department of Medical Research, Advanced Therapeutic & Pharmaceutical Center, China Medical University Hospital, Taichung, Taiwan; Drug Development Center, China Medical University, Taichung, Taiwan; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan., Pan CM; Department of Medical Research, Advanced Therapeutic & Pharmaceutical Center, China Medical University Hospital, Taichung, Taiwan., Huang SW; Department of Medical Research, Advanced Therapeutic & Pharmaceutical Center, China Medical University Hospital, Taichung, Taiwan; Drug Development Center, China Medical University, Taichung, Taiwan., Fang HY; Division of Thoracic Surgery, Department of Surgery, China Medical University Hospital, Taichung, Taiwan; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan., Chen YW; Department of Medical Research, Advanced Therapeutic & Pharmaceutical Center, China Medical University Hospital, Taichung, Taiwan; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan., Kan KW; Department of Medical Research, Advanced Therapeutic & Pharmaceutical Center, China Medical University Hospital, Taichung, Taiwan; Department of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan., Huang KC; Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan; Translation Research Core, China Medical University Hospital, China Medical University, Taichung, Taiwan., Chen MC; Department of Medical Research, Advanced Therapeutic & Pharmaceutical Center, China Medical University Hospital, Taichung, Taiwan. Electronic address: 033019@tool.caaumed.org.tw.
Source: International immunopharmacology [Int Immunopharmacol] 2026 Jul 14; Vol. 186, pp. 117115. Date of Electronic Publication: 2026 Jul 14.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-1705
DOI:10.1016/j.intimp.2026.117115